Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v3-EN Version v2-FR
Language English French
Date Updated 2018-09-07 2018-06-05
Drug Identification Number 02245273 02245273
Brand name AMARYL AMARYL
Common or Proper name Amaryl 2mg Amaryl 2mg
Company Name SANOFI-AVENTIS CANADA INC SANOFI-AVENTIS CANADA INC
Ingredients GLIMEPIRIDE GLIMEPIRIDE
Strength(s) 2MG 2MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 30 30
ATC code A10BB A10BB
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2018-08-31 2018-08-31
Actual discontinuation date 2018-07-10
Remaining supply date 2018-08-31 2018-08-31
Discontinuation status Discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments